Literature DB >> 26751400

Biochemical, immunological and kinetic characterization and partial sequence analysis of a thiol proteinase inhibitor from Bubalus bubalis kidney: An attempt targeting kidney disorders.

Anas Shamsi1, Azaj Ahmed1, Bilqees Bano2.   

Abstract

In the present study a thiol proteinase inhibitor was isolated from buffalo kidney making use of ammonium sulphate precipitation and gel filtration chromatography on Sephacryl S-100HR column. Purified inhibitor is homogeneous as it displayed a single band in gel electrophoresis both under reducing and non-reducing environment and is of 65KDa as revealed by gel filtration and SDS PAGE. Kinetic studies revealed the presence of reversible accompanied with competitive mode of inhibition; showing maximum efficacy against papain (Ki=2.90×10-4). It was maximally active at pH 8.0 and was stable for a period of 30, 60 and 90 days at 37, 4 and -20°C respectively. Immunological studies confirmed its purity of epitopes as a single precipitin line is obtained in immunodiffusion. N-terminal analysis revealed that it shared a good homology with mouse kidney cystatin as well as with Human Cys C and Cys E thereby advocating its use as a model for various human oriented studies which targets how the kidney cystatin level varies in accordance with various drugs that are currently being used as a target for variety of diseases.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cystatin; N-terminal analysis; Papain

Mesh:

Substances:

Year:  2016        PMID: 26751400     DOI: 10.1016/j.ijbiomac.2015.12.084

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  2 in total

Review 1.  Journey of cystatins from being mere thiol protease inhibitors to at heart of many pathological conditions.

Authors:  Anas Shamsi; Bilqees Bano
Journal:  Int J Biol Macromol       Date:  2017-04-23       Impact factor: 6.953

2.  Identification of Cysteine Protease Inhibitor CST2 as a Potential Biomarker for Colorectal Cancer.

Authors:  Qiurong Xie; Liya Liu; Xiaoping Chen; Ying Cheng; Jiapeng Li; Xiuli Zhang; Nanhui Xu; Yuying Han; Huixin Liu; Lihui Wei; Jun Peng; Aling Shen
Journal:  J Cancer       Date:  2021-06-22       Impact factor: 4.207

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.